UnitedHealth’s Optum in lead for Riordan, Lewis & Haden-backed Avella Specialty Pharmacy

AlliancePharma Inc
  • LA-based RL&H's investment dates to February 2009
  • Sum of the parts transaction was also considered
  • Sell-side advisers: Raymond James and BofA
UnitedHealth Group’s Optum subsidiary is nearing a deal to acquire Avella Specialty Pharmacy from Riordan, Lewis & Haden, according to sources with knowledge of the matter. The anticipated transaction comes about nine years after Riordan, Lewis & Haden acquired a ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition


To read a digital copy of our latest magazine

click here

PE News Briefs